Derbyshire Medicines Management and Clinical Policies
Neutral soluble long-acting insulin analogue and GLP1.
JAPC diabetes guideline does not recommend GLP1 in combination with basal insulin, furthermore monotherapy with either of these drugs are not listed as first-line options.
